SCHEMBL8540511

SCHEMBL8540511

CO[C@H](C(=O)N1CCCC[C@@H]1c1ccccc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 2/20 0.51
HSD11B1 P28845 1/20 0.46
ADAM17 P78536 3/20 0.45
RAB9A P51151 1/20 0.44
ROCK2 O75116 1/20 0.44
PRMT5 O14744 4/20 0.43
WDR77 Q9BQA1 4/20 0.43
PARP14 Q460N5 1/20 0.43
PARP10 Q53GL7 1/20 0.43
HSP90AA1 P07900 1/20 0.43
HSP90AB1 P08238 1/20 0.43
BACE1 P56817 1/20 0.42
SLC6A3 Q01959 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8540509 1.00 RIPK1 (0.51) RIPK1HSD11B1ADAM17RAB9AROCK2
SCHEMBL8546239 1.00 RIPK1 (0.51) RIPK1HSD11B1ADAM17RAB9AROCK2
SCHEMBL8545905 0.99 RIPK1 (0.50) RIPK1HSD11B1ADAM17RAB9AROCK2
SCHEMBL8539202 0.99 RIPK1 (0.50) RIPK1HSD11B1ADAM17RAB9AROCK2
SCHEMBL8540459 0.96 RIPK1 (0.56) RIPK1HSD11B1ADAM17RAB9AHSP90AA1
SCHEMBL8540457 0.96 RIPK1 (0.56) RIPK1HSD11B1ADAM17RAB9AHSP90AA1
SCHEMBL6436515 0.79 ALDH1A1 (0.53)
SCHEMBL6435766 0.79 ALDH1A1 (0.53)
SCHEMBL6436519 0.79 ALDH1A1 (0.53)
SCHEMBL6435771 0.79 ALDH1A1 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0705259-B1 PHENYRROLE DERIVATIVES AND THEIR USE AS DOPAMINE D3 ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1998-02-25 EP disclosed
EP-0705259-A1 PHENYRROLE DERIVATIVES AND THEIR USE AS DOPAMINE D3 ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-04-10 EP disclosed
WO-1995000508-A1 PHENYRROLE DERIVATIVES AND THEIR USE AS DOPAMINE D3 ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-01-05 WO disclosed